Who mentions $HYFT most on Surfaced?

@moninvestor (mon) mentions $HYFT most — 5 mentions in the past 12 months.

When was $HYFT first mentioned on Surfaced?

The earliest tracked mention of $HYFT in the Surfaced archive was on Jan 8, 2026.

How many voices track $HYFT?

2 FinTwit voices have mentioned $HYFT 6 times in the past 12 months.

What kind of voices mention $HYFT most?

$HYFT is mentioned most by Long Research voices on Surfaced.

Last 12mo stats

mentions

voices

$HYFT

MindWalk Holdings Corp

$HYFT

MindWalk Holdings Corp

Past 12mo:6mentions2voices

All voices6 mentions since Jan 2026calls only

Loading price chart…

About this stock

$HYFT has been mentioned 6 times over the past 12 months by 2 distinct FinTwit voices, with the first mention appearing on January 8, 2026. The most active voice discussing $HYFT is @moninvestor (mon), who has mentioned the ticker 5 times, while @investmentguru_ has mentioned it once. The most recent mention occurred on March 3, 2026, when @moninvestor included $HYFT in a list of stocks currently under research alongside tickers such as $IBRX, $POET, and $REAX.

AI-generated from tracked posts · updated Sep 5, 2026

Frequently asked

Related stocks

$ZENAZenaTech

$ADURAduro Clean Technologies

$NAKNorthern Dynasty Minerals

$AIRJAirjoule Technologies

Recent mentions

6 mentions

@moninvestorMar 3, 2026 · 11:16 PM

My current portfolio: LT: $IREN $ONDS $KRKNF ST: $UAMY $AXTI $TE $ALMU $OUST $NUAI $OSS Researching: $IBRX, $HYFT, $POET, $REAX, $LAES, $SATS, $JOBY, $COPX & $USAR. ✍️

Open on X

@investmentguru_Feb 19, 2026 · 3:29 AM

Volatility Is Noise. Positioning Is Power My favourite 20 $PLTR $SOFI $RKLB $ASTS $ENPH $PATH $ZETA $SNAP $ABCL $KRKNF $UAMY $ONDS $EOSE $HYFT $JOBY $ACHR $TE $IREN $CIFR $UBER So many great stocks. So little capital. The key isn’t chasing what’s up. It’s building exposure to secular trends and adding on pullbacks. not a financial advise

Open on X

@moninvestorFeb 18, 2026 · 6:00 PM

So many great stocks, so little capital. 🧐 If I were building my own ETF: $IREN $ONDS $CIFR $NBIS $WULF $IBRX $PL $ASTS $RKLB $NUAI $POET $ALMU $KRKNF $UAMY $COPX $OUST $TE $ENPH $OSS $SNAP $HIMS (depends on earnings) $PATH $ZETA $EOSE $JOBY $ACHR $LAES $ABCL $PRME $HYFT Top 30 > not in order.

Open on X

@moninvestorJan 15, 2026 · 4:01 PM

Update your watchlist: $HYFT, $PRME, $CRML, $UMAC, $ADUR, $TSSI, $PSIX, $SKYT, $EOSE, $ASST, $MSTR, $SERV, $RR, $TGEN, $OUST, $BZAI, $SLNH, $JOBY, $SEZL, $DAVE, $PPIH, $REAX, and $ZENA. 👀

Open on X

@moninvestorJan 12, 2026 · 12:59 PM

Bought a new stock. MindWalk $HYFT. I’m starting in-depth research across the biotechnology sector. +18.01% Pre-Market - MindWalk says it has identified a functional pattern in influenza viruses that remains present even as the virus evolves. Using its patented HYFT Deep Data technology, the company analyzes biophysical and functional constraints that influenza must satisfy to remain viable. These are not conserved genetic sequences, but deeper biological constraints embedded in influenza’s functional biology. According to the press release, this pattern has been observed across influenza A and influenza B, including currently circulating H3N2 variants, avian influenza A subtypes (H5, H7, H9), swine-associated H1N1, and both influenza B Victoria and Yamagata lineages. MindWalk describes this as a constraint that persists beneath surface-level genetic change. MindWalk frames the discovery as a way to move beyond traditional surveillance that focuses on sequence changes, toward an approach based on what the virus cannot change without losing core function. The company says this could support rational vaccine design and other interventions that target these constraints. MindWalk plans to expand this work through additional pre-clinical validation and IND-enabling activities within a dedicated influenza program portfolio. After de-risking in pre-clinical work, the company intends to out-license the program or enter strategic partnerships with larger pharmaceutical companies to advance late-stage development and commercialization. This finding represents an early research milestone and does not yet demonstrate practical clinical results. I first bought the stock last week and booked a 10% profit. The stock is currently up 18.01%.

Open on X

@moninvestorJan 8, 2026 · 2:14 AM

@yeah_dave $HYFT 👀

Open on X